119 related articles for article (PubMed ID: 18306415)
1. How to implement the modified international normalized ratio for cirrhosis (INR(liver)) for model for end-stage liver disease calculation.
Tripodi A
Hepatology; 2008 Apr; 47(4):1423-4; author reply 1424. PubMed ID: 18306415
[No Abstract] [Full Text] [Related]
2. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology.
Bellest L; Eschwège V; Poupon R; Chazouillères O; Robert A
Hepatology; 2007 Aug; 46(2):528-34. PubMed ID: 17654598
[TBL] [Abstract][Full Text] [Related]
3. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease.
Tripodi A; Caldwell SH; Hoffman M; Trotter JF; Sanyal AJ
Aliment Pharmacol Ther; 2007 Jul; 26(2):141-8. PubMed ID: 17593061
[TBL] [Abstract][Full Text] [Related]
4. Determining the model for end-stage liver disease with better accuracy: neutralizing the international normalized ratio pitfalls.
Marlar RA
Hepatology; 2007 Aug; 46(2):295-6. PubMed ID: 17661420
[No Abstract] [Full Text] [Related]
5. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation.
Tripodi A; Chantarangkul V; Primignani M; Fabris F; Dell'Era A; Sei C; Mannucci PM
Hepatology; 2007 Aug; 46(2):520-7. PubMed ID: 17659574
[TBL] [Abstract][Full Text] [Related]
6. The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure.
Kamath PS; Kim WR
Clin Liver Dis; 2009 Feb; 13(1):63-66. PubMed ID: 19150310
[TBL] [Abstract][Full Text] [Related]
7. [A discussion of standardization for prothrombin time in patients with advanced liver diseases].
Li Q; Cong YL; Wang BE; Jia JD; Chen Y; Zhang FK; Ou XJ; Wei YX; Ma H
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):128-31. PubMed ID: 15727702
[TBL] [Abstract][Full Text] [Related]
8. International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure.
Arjal R; Trotter JF
Clin Liver Dis; 2009 Feb; 13(1):67-71. PubMed ID: 19150311
[TBL] [Abstract][Full Text] [Related]
9. The prothrombin time-derived international normalized ratio: great for Warfarin, fair for prognosis and bad for liver-bleeding risk.
Caldwell S; Shah N
Liver Int; 2008 Dec; 28(10):1325-7. PubMed ID: 19055640
[No Abstract] [Full Text] [Related]
10. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
Choi PC; Kim HJ; Choi WH; Park DI; Park JH; Cho YK; Sohn CI; Jeon WK; Kim BI
Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
[TBL] [Abstract][Full Text] [Related]
11. Interlaboratory variability in assessment of the model of end-stage liver disease score.
Lisman T; van Leeuwen Y; Adelmeijer J; Pereboom IT; Haagsma EB; van den Berg AP; Porte RJ
Liver Int; 2008 Dec; 28(10):1344-51. PubMed ID: 18482269
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
Sun QF; Ding JG; Xu DZ; Chen YP; Hong L; Ye ZY; Zheng MH; Fu RQ; Wu JG; Du QW; Chen W; Wang XF; Sheng JF
J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the international normalized ratio (INR)].
Sousa SR
Acta Med Port; 1998; 11(8-9):773-7. PubMed ID: 9951071
[TBL] [Abstract][Full Text] [Related]
14. False incoagulable PT-INR results in oral anticoagulant therapy.
Redaelli R; Corno AR; Somaini MG; Gechtman C; Caimi TM; Baudo F; Morra E
Thromb Res; 2008; 122(1):137-9. PubMed ID: 17996923
[No Abstract] [Full Text] [Related]
15. [Choice of PT-INR instruments in primary health care].
Stavelin A; Omenås B; Bolann B; Christensen NG; Sandberg S
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2620. PubMed ID: 19023367
[No Abstract] [Full Text] [Related]
16. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.
Xiol X; Gines P; Castells L; Twose J; Ribalta A; Fuentes-Arderiu X; Rodriguez S; Castellote J; Navasa M; Deulofeu R
Liver Transpl; 2009 Mar; 15(3):300-5. PubMed ID: 19242993
[TBL] [Abstract][Full Text] [Related]
17. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
Peng L; Yan C; Wu X; Nie L
Int J Lab Hematol; 2009 Jun; 31(3):352-8. PubMed ID: 18510575
[TBL] [Abstract][Full Text] [Related]
18. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
Cuomo O; Perrella A; Arenga G
Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
[TBL] [Abstract][Full Text] [Related]
19. A national field study of quality assessment of CoaguChek point-of-care testing prothrombin time monitors.
Meijer P; Kluft C; Poller L; van der Meer FJ; Keown M; Ibrahim S; van den Besselaar AM; Tripodi A; Jespersen J
Am J Clin Pathol; 2006 Nov; 126(5):756-61. PubMed ID: 17050073
[TBL] [Abstract][Full Text] [Related]
20. Standardization of the INR: how good is your laboratory's INR and can it be improved?
Favaloro EJ; Adcock DM
Semin Thromb Hemost; 2008 Oct; 34(7):593-603. PubMed ID: 19085760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
